ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2019

Combined administration of anti-IL-13 and anti-IL-17A at individually sub-therapeutic doses limits asthma-like symptoms in a mouse model of Th2/Th17 high asthma.

Dasom Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.